Saturday 27 February 2021

FDA Withdraws Durvalumab Indication For Bladder Cancer

Immunotherapy drug- Durvalumab's indication for the treatment of bladder cancer has been withdrawn in the US after it failed to improve survival.


from Medindia Health News https://ift.tt/2ZW91Q5

No comments:

Post a Comment